Novoheart’s Unique Human Heart-In-A-Jar™,
and array of tissue modeling solutions, enable a comprehensive range of services to fulfill your scientific needs
Novoheart can differentiate your pluripotent stem cells into ventricular cardiomyocytes and bioengineer a suite of advanced functional engineered human tissue models. We can provide preclinical human-specific electrophysiology, arrhythmia, contractility, and pressure-volume data for your specified disease model to help advance your therapeutic candidate toward regulatory approval.
Our contract services are enabled by our unique human heart-in-a-jar™, anisotropic sheet, and tissue strip assays. These allow us to offer customized pharmaceutical drug development services, drug discovery, and research and development / consultation related to new disease models and therapeutics.
Service Offerings
Accelerate your scientific studies by leveraging Novoheart’s expertise in cardiac biotechnology and pharmaceutical research. Areas include but are not limited to:
•Human embryonic or induced pluripotent stem cell differentiation to ventricular cardiomyocytes
•Mini-Heart Engineered Tissue Assays Using Specified Cell Lines – see Our Platform page for more details on these assays
•Human Ventricular Cardiac Anisotropic Sheet (hvCAS)
•Human Ventricular Cardiac Tissue Strip (hvCTS)
•Human Heart-in-a-Jar™, also known as the Human Ventricular Cardiac Organoid Chamber (hvCOC)
•Drug discovery
•Cardiotoxicity screening
•Disease modeling of rare/genetic and acquired heart diseases
•Efficacy studies
•Dose titration and optimization
•Patient cohort-specific responses to drug treatments
•Screening and phenotyping services
One-stop service using the proprietary and modularly designed MyHeart™ platform
Below is a representative multi-step work flow, but any of these steps are available as standalone services or in combinations.
Please contact us to discuss the study you have in mind.
